CD8<sup>+</sup> T‐cell specificity is compromised at a defined MHCI/CD8 affinity threshold

Tamsin Dockree, Christopher J. Holland, Mathew Clement, Kristin Ladell, James E. McLaren, Hugo A. van den Berg, Emma Gostick, Kelly L. Miners, Sian Llewellyn‐Lacey, John S. Bridgeman,

Immunology and Cell Biology · 2016 · 17 citations · 32 references

DOIFull text

Open access

Concepts

Abstract

The CD8 co‐receptor engages peptide‐major histocompatibility complex class I (pMHCI) molecules at a largely invariant site distinct from the T‐cell receptor (TCR)‐binding platform and enhances the sensitivity of antigen‐driven activation to promote effective CD8 + T‐cell immunity. A small increase in the strength of the pMHCI/CD8 interaction (~1.5‐fold) can disproportionately amplify this effect, boosting antigen sensitivity by up to two orders of magnitude. However, recognition specificity is lost altogether with more substantial increases in pMHCI/CD8 affinity (~10‐fold). In this study, we used a panel of MHCI mutants with altered CD8‐binding properties to show that TCR‐mediated antigen specificity is delimited by a pMHCI/CD8 affinity threshold. Our findings suggest that CD8 can be engineered within certain biophysical parameters to enhance the therapeutic efficacy of adoptive T‐cell transfer irrespective of antigen specificity.

References

32